Supplementary Table S5 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma

Supplementary Table S5 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma

<p>Supplementary Table S5A. Bulk-level single cell ATAC sequencing analysis showing immediate (short-term) chromatin openings (peaks) in HN30-P cells following CDDP treatment; Supplementary Table S5B. Bulk-level single cell ATAC sequencing analysis showing long-term chromatin openings (peaks)...

全面介绍

Saved in:
书目详细资料
主要作者: Abdullah A. Osman (15056323) (author)
其他作者: Emre Arslan (15056326) (author), Mason Bartels (15056329) (author), Chieko Michikawa (15056332) (author), Antje Lindemann (15056335) (author), Katarzyna Tomczak (15056338) (author), Wangjie Yu (15056341) (author), Vlad Sandulache (15056344) (author), Wencai Ma (15056347) (author), Li Shen (14959241) (author), Jing Wang (14959256) (author), Anand K. Singh (15056350) (author), Mitchell J. Frederick (14959253) (author), Nakia D. Spencer (15056353) (author), Jeffery Kovacs (15056356) (author), Timothy Heffernan (15056359) (author), William F. Symmans (15056362) (author), Kunal Rai (15056365) (author), Jeffrey N. Myers (15026901) (author)
出版: 2025
主题:
Cancer
Cancer Risk Factors
Tumor Biology
Molecular and Cellular Biology
Therapeutic Research and Development
Methods and Technology
Drug Resistance
Drug Targets
Epigenetics
Epigenomics
Head, Neck & Oral Cancers
Preclinical Models
Progression, Invasion & Metastasis
Tumor progression
Small Molecule Agents
标签: 添加标签
没有标签, 成为第一个标记此记录!
实物特征
总结:<p>Supplementary Table S5A. Bulk-level single cell ATAC sequencing analysis showing immediate (short-term) chromatin openings (peaks) in HN30-P cells following CDDP treatment; Supplementary Table S5B. Bulk-level single cell ATAC sequencing analysis showing long-term chromatin openings (peaks) gained in cisplatin-resistant HN30-R8 cells following CDDP treatment.</p>

相似书籍